ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Regulatory T Cells Suppress Memory IL-17a Production in Highly Sensitised Patients with End-Stage Renal Disease

C. Dudreuilh1, S. Basu1, O. Shaw2, H. Burton1, C. Domingo-Vila1, T. Tree1, G. Lombardi1, C. Scotta1, A. Dorling1

1King's College London, London, United Kingdom, 2Viapath Clinical Transplantation Laboratory, Guy's Hospital, London, United Kingdom

Meeting: 2022 American Transplant Congress

Abstract number: 1257

Keywords: Alloantibodies, Highly-sensitized, Kidney transplantation, T cells

Topic: Basic Science » Basic Science » 10 - Treg/Other Regulatory Cell/Tolerance

Session Information

Session Name: Treg/Other Regulatory Cell/Tolerance

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Highly sensitised patients exhibit poorer long-term outcomes following renal transplantation compared to those non sensitised individuals. IL17-A has been associated with acute rejection. Presence of regulatory T cells (Tregs) has been associated with regulation in patients with chronic rejection. Therapy using autologous expanded Tregs has been demonstrated to be safe. This project aims to test the hypothesis that Tregs could be used in sensitised patients to suppress memory IL-17A responses.

*Methods: We prospectively recruited highly-sensitised patients on haemodialysis, isolated their Tregs and expanded them using established protocols (Interleukin-2 + Rapamycin). IL-17A production by CD8-depleted peripheral blood mononuclear cells (PBMC)(+/- additional depletion of CD25hi cells) in response to Human Leucocyte Antigen (HLA) proteins (PureProt®) was tested in FluoroSpot to assess the memory immune alloresponses at baseline and when expanded autologous Tregs were also added.

*Results: Of the patients included, 10/16 were sensitised by previous renal transplant and of those 4/10 had had nephrectomy. 4/10 (40%) of post-transplant patients were on immunosuppression. We managed to expand Tregs for 11/16 (69%) patients (Figure 1). Five/11 (45%) patients had spontaneous IL-17A production in CD8-depleted PBMCs challenged with an HLA protein that they had been sensitised to (Figure 2). In 4/5 patients (80%), IL-17A production was reduced when autologous ex vivo expanded Tregs were added. Moreover, in 6/11 (55%) patients, CD8-CD25hi- PBMCs stimulated with pure HLA protein were associated with IL-17A production, which was suppressed in 4/6 when expanded autologous Tregs were also added.

*Conclusions: Forty-five percent of HS patients made IL-17A when challenged by an HLA protein they have made an HLA antibody against. In most of these patients, IL-17A could be inhibited by autologous ex vivo expanded Tregs. The Phase IIa trial GAMECHANgER-1 will test whether these findings are reproducible in vivo in HS patients awaiting renal transplantation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Dudreuilh C, Basu S, Shaw O, Burton H, Domingo-Vila C, Tree T, Lombardi G, Scotta C, Dorling A. Regulatory T Cells Suppress Memory IL-17a Production in Highly Sensitised Patients with End-Stage Renal Disease [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/regulatory-t-cells-suppress-memory-il-17a-production-in-highly-sensitised-patients-with-end-stage-renal-disease/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences